Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals

Molecular and Cellular Biology

Volumn 19, Issue 7, 1999, Pages 4633-4642

  Marston, Nicola J ^a   Richards, William J ^a   Hughes, David ^a   Bertwistle, David ^a   Marshall, Christopher J ^a   Ashworth, Alan ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; DNA HYBRIDIZATION; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SUPPRESSOR GENE;

MAMMALIA; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE;

EID: 0033026065     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.7.4633     Document Type: Article

References (54)

1. Achille, A., M. O. Biasi, G. Zamboni, G. Bogina, A. R. Magalini, P. Pederzoli, M. Perucho, and A. Scarpa. 1996. Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res 56:3808-3813.
2. Basi, G., E. Schmid, and K. Maundrell. 1993. TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility. Gene 123: 131-136.
3. Bertwistle, D., and A. Ashworth. 1998. Functions of the BRCA1 and BRCA2 genes. Curr. Opin. Genet. Dev. 8:14-20.
4. Bertwistle, D., S. Swift, N. J. Marston, L. E. Jackson, S. Crossland, M. R. Crompton, C. J. Marshall, and A. Ashworth. 1997. Nuclear location and cell cycle regulation of the BRCA2 protein. Cancer Res 57:5485-5488.
5. Bignell, G., G. Micklem, M. R. Stratton, A. Ashworth, and R. Wooster. 1997. The BRC repeats are conserved in mammalian BRCA2 proteins. Hum. Mol. Genet. 6:53-58.
6. Bork, P., N. Blomberg, and M. Nilges, 1996. Internal repeats in the BRCA2 protein sequence. Nat. Genet. 13:22-23.
7. Brewster, J. L., T. de Valoir, N. D. Dwyer, E. Winter, and M. C. Gustin. 1993. An osmosensing signal transduction pathway in yeast. Science 259:1760-1763.
8. Chen, J., D. P. Silver, D. Walpita, S. B. Cantor, A. F. Gazdar, G. Tomlinson, F. J. Couch, B. L. Weber, T. Asbley, D. M. Livingston, and R. Scully. 1998. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2:317-328.
9. Collins, N., R. McManus, R. Wooster, J. Mangion, S. Seal, S. R. Lakhani, W. Ormiston, P. A. Daly, D. Ford, D. F. Easton, et al. 1995. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10:1673-1675.
10. Connor, F., D. Bertwistle, P. J. Mee, G. M. Ross, S. Swift, E. Grigorieva, V. L. Tybulewicz, and A. Ashworth. 1997. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17:423-430.
11. Connor, F., A. Smith, R. Wooster, M. Stratton, A. Dixon, E. Campbell, T. M. Tait, T. Freeman, and A. Ashworth. 1997. Cloning, chromosomal mapping and expression pattern of the mouse Brca2 gene. Hum. Mol. Genet. 6:291-300.
12. Couch, F. J., L. M. Fand, M. L. DeShano, S. V. Tavtigian, K. Calzone, L. Campeau, Y. Peng, B. Bogden, Q. Chen, S. Neuhausen, D. Shattuck-Eidens, A. K. Godwin, M. Daly, D. M. Radford, S. Sedlacek, J. Rommens, J. Simard, J. Garber, S. Merajver, and B. L. Weber. 1996. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet. 13:123-125.
13. Crackower, M. A., S. W. Scherer, J. M. Rommens, C. C. Hui, P. Poorkaj, S. Soder, J. M. Cobben, L. Hudgins, J. P. Evans, and L. C. Tsui. 1996. Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum. Mol. Genet. 5:571-579.
14. Evan, G. I., G. K. Lewis, G. Ramsay, and J. M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
15. Forsburg, S. 11 February 1999, revision date. Yeast flow cytometry protocol. [Online.] http://pingu.salk.edu/fcm/protocols/ycc.html. [11 February 1999, last date accessed.]
16. Friedman, L. S., F. C. Thistlethwaite, K. J. Patel, V. P. Yu, H. Lee, A. R. Venkitaraman, K. J. Abel, M. B. Carlton, S. M. Hunter, W. H. Colledge, M. J. Evans, and B. A. Ponder. 1998. Thymic lymphomas in mice with a truncating mutation in Brca2. Cancer Res. 58:1338-1343.
17. Gayther, S. A., J. Mangion, P. Russell, S. Seal, R. Barfoot, B. A. Ponder, M. R. Stratton, and D. Easton. 1997. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat. Genet. 15:103-105.
18. Gould, K. L., S. Moreno, D. J. Owen, S. Sazer, and P. Nurse. 1991. Phosphorylation at Thr167 is required for Schizosaccharomyces pombe p34cdc2 function. EMBO J. 10:3297-3309.
19. Gretarsdottir, S., S. Thorlacius, R. Valgardsdottir, S. Gudlaugsdottir, S. Sigurdsson, M. Steinarsdottir, J. G. Jonasson, K. Anamthawat-Jonsson, and J. E. Eyfjord. 1998. BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability. Cancer Res. 58:859-862.
20. Gudmundsson, J., G. Johannesdottir, J. T. Bergthorsson, A. Arason, S. Ingvarsson, V. Egilsson, and R. B. Barkardottir. 1995. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 55:4830-4832.
21. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
22. Ignatius, J., S. Knuutila, S. W. Scherer, B. Trask, and J. Kere. 1996. Split hand/split foot malformation, deafness, and mental retardation with a complex cytogenetic rearrangement involving 7q21.3. J. Med. Genet. 33:507-510.
23. Ingvarsson, S., E. K. Geirsdottir, G. Johannesdottir, B. I. Sigbjornsdottir, G. Eiriksdottir, G. Ragnarsson, B. A. Agnarsson, J. Gudmundsson, J. G. Jonasson, A. Sigurdsson, V. Egilsson, and R. B. Barkardottir. 1998. High incidence of loss of heterozygosity in breast tumors from carriers of the BRCA2 999del5 mutation. Cancer Res. 58:4421-4425.
24. Jantti, J., J. Lahdenranta, V. M. Olkkonen, H. Soderlund, and S. Keranen. 1999. SEM1, a homologue of the split hand/split food malformation candidate gene Dss1, regulates exocytosis and pseudohyphal differentiation in yeast. Proc. Natl. Acad. Sci. USA 96:909-914.
25. Kristjansson, A. K., G. Eiriksdottir, G. Ragnarsson, A. Sigurdsson, J. Gudmundsson, R. B. Barkardottir, J. G. Jonasson, V. Egilsson, and S. Ingvarsson. 1997. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. Anticancer Res. 17:93-98.
26. Ludwig, T., D. L. Chapman, V. E. Papaioannou, and A. Efstratiadis. 1997. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 11:1226-1241.
27. Marais, R., Y. Light, H. F. Paterson, and C. J. Marshall. 1995. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J. 14:3136-3145.
28. Marston, N. Unpublished data.
29. Mazoyer, S., A. M. Dunning, O. Serova, J. Dearden, N. Puget, C. S. Healey, S. A. Gayther, J. Mangion, M. R. Stratton, H. T. Lynch, D. E. Goldgar, B. A. Ponder, and G. M. Lenoir. 1996. A polymorphic stop codon in BRCA2. Nat. Genet. 14:253-254.
30. Miki, Y., T. Katagiri, F. Kasumi, T. Yoshimoto, and Y. Nakamura. 1996. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet. 13:245-247.
31. Milner, J., B. Ponder, L. Hughes-Davies, M. Seltmann, and T. Kouzarides. 1997. Transcriptional activation functions in BRCA2. Nature 386:772-773.
32. Mizuta, R., J. M. LaSalle, H. L. Cheng, A. Shinohara, H. Ogawa, N. Copeland, N. A. Jenkins, M. Lalande, and F. W. Alt. 1997. RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein. Proc. Natl. Acad. Sci. USA 94:6927-6932.
33. Moreno, S., A. Klar, and P. Nurse. 1991. Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol. 194:795-823.
34. Morimatsu, M., G. Donoho, and P. Hasty. 1998. Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. Cancer Res. 58:3441-3447.
35. Neuhausen, S., T. Gilewski, L. Norton, T. Tran, P. McGuire, J. Swensen, H. Hampel, P. Borgen, K. Brown, M. Skolnick, D. Shattuck-Eidens, S. Jhanwar, D. Goldgar, and K. Offit. 1996. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat. Genet. 13:126-128.
36. Patel, K. J., V. P. Vu, H. Lee, A. Corcoran, F. C. Thistletbwaite, M. J. Evans, W. H. Colledge, L. S. Friedman, B. A. Ponder, and A. R. Venkitaraman. 1998. Involvement of Brca2 in DNA repair. Mol. Cell 1:347-357.
37. Phelan, C. M., J. M. Lancaster, P. Tonin, C. Gumbs, C. Cochran, R. Carter, P. Ghadirian, C. Perret, R. Moslehi, F. Dion, M. C. Faucher, K. Dole, S. Karimi, W. Foulkes, H. Lounis, E. Warner, P. Goss, D. Anderson, C. Larsson, S. A. Narod, and P. A. Futreal. 1996. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet. 13:120-122.
38. Rajan, J. V., S. T. Marquis, H. P. Gardner, and L. A. Chodosh. 1997. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev. Biol. 184:385-401.
39. Rothstein, R. J. 1983. One-step gene disruption in yeast. Methods Enzymol. 101:202-211.
40. Schaap, D., J. van der Wal, L. R. Howe, C. J. Marshall, and W. J. van Blitterswijk. 1993. A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras. J. Biol. Chem. 268:20232-20236.
41. Scherer, S. W., P. Poorkaj, T. Allen, J. Kim, D. Geshuri, M. Nunes, S. Soder, K. Stephens, R. A. Pagon, M. A. Patton, et al. 1994. Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am. J. Hum. Genet. 55:12-20.
42. Scully, R., J. Chen, A. Plug, Y. Xiao, D. Weaver, J. Feunteun, T. Ashley, and D. M. Livingston. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275.
43. Sharan, S. K., M. Morimatsu, U. Albrech, D. S. Lim, E. Regel, C. Dinh, A. Sands, G. Eichele, P. Hasty, and A. Bradley. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386:804-810.
44. Shinohara, A., H. Ogawa, and T. Ogawa. 1992. Rad51 protein involved in repair and recombination in S. cerevisiae is a RecA-like protein. Cell 69: 457-470.
45. Siddique, H., J. P. Zou, V. N. Rao, and E. S. Reddy. 1998. The BRCA2 is a histone acetyltransferase. Oncogene 16:2283-2285.
46. Sigurdsson, S., S. Thorlacius, J. Tomasson, L. Tryggvadottir, K. Benediktsdottir, J. E. Eyfjord, and E. Jonsson. 1997. BRCA2 mutation in Icelandic prostate cancer patients. J. Mol. Med. 75:758-761.
47. Simeone, A., D. Acampora, M. Pannese, M. D'Esposito, A. Stornaiuolo, M. Gulisano, A. Mallamaci, K. Kastury, T. Druck, K. Huebner, et al. 1994. Cloning and characterization of two members of the vertebrate Dlx gene family. Proc. Natl. Acad. Sci. USA 91:2250-2254.
48. Suzuki, A., J. L. de la Pompa, R. Hakem, A. Elia, R. Yoshida, R. Mo, H. Nishina, T. Chuang, A. Wakeham, A. Itie, W. Koo, P. Billia, A. Ho, M. Fukumoto, C. C. Hui, and T. W. Mak. 1997. Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev. 11:1242-1252.
49. Tavtigian, S. V., J. Simard, J. Kommens, F. Couch, D. Shattuck-Eidens, S. Neuhausen, S. Merajver, S. Thorlacius, K. Offit, D. Stoppa-Lyonnet, C. Belanger, R. Bell, S. Berry, R. Bogden, Q. Chen, T. Davis, M. Dumont, C. Frye, T. Hattier, S. Jammulapati, T. Janecki, P. Jiang, R. Kehrer, J. F. Leblanc, D. E. Goldgar, et al. 1996. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet. 12:333-337.
50. Teng, D. H., R. Bogden, J. Mitchell, M. Baumgard, R. Bell, S. Berry, T. Davis, P. C. Ha, R. Kehrer, S. Jammulapati, Q. Chen, K. Offit, M. H. Skolnick, S. V. Tavtigian, S. Jhanwar, B. Swedlund, A. K. Wong, and A. Kamb. 1996. Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat. Genet. 13:241-244.
51. Thorlacius, S., G. Olafsdottir, L. Tryggvadottir, S. Neuhausen, J. G. Jonasson, S. V. Tavtigian, H. Tulinius, H. M. Ogmundsdottir, and J. E. Eyfjord. 1996. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 13:117-119.
52. Vaisman, N., A. Tsouladze, K. Robzyk, S. Ben-Yehuda, M. Kupiec, and Y. Kassir. 1995. The role of Saccharomyces cerevisiae Cdc40p in DNA replication and mitotic spindle formation and/or maintenance. Mol. Gen. Genet. 247:123-136.
53. Wong, A. K. C., R. Pero, P. A. Ormonde, S. V. Tavtigian, and P. L. Bartel. 1997. RAD51 interacts with the evolutionary conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272:31941-31948.
54. Wocster, R., G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, G. Micklem, et al. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.